Cullinan Therapeutics (CGEM) Common Equity (2020 - 2026)
Cullinan Therapeutics' Common Equity came in at $321.75 million for Q2 2026, down 34.6% from $492.15 million a year earlier and down 12.1% from the prior quarter.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Cullinan Therapeutics' Common Equity was $408.73 million, down 30.8% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 15.3% (FY2020 to FY2025).
- Going back by year, Common Equity was $590.33 million in FY2024 (+30.1%), $453.9 million in FY2023 (-15.2%), $535.03 million in FY2022 (+25.8%) and $425.37 million in FY2021 (+112.4%).
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q4 2020.
- Year-over-year, Common Equity has declined for five consecutive quarters, with an average decline of 7.3% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q3 2021 (growth of 397.7%), and the weakest in Q2 2026 (a decline of 34.6%).
- Business Quant data shows CGEM's Common Equity at $366.17 million (Q1 2026), $408.73 million (Q4 2025) and $451.37 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Cullinan Therapeutics | 961.97 Mn | 961.97 Mn | - | 321.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 321.75 Mn |
| Mar 31, 2026 | 366.17 Mn |
| Dec 31, 2025 | 408.73 Mn |
| Sep 30, 2025 | 451.37 Mn |
| Jun 30, 2025 | 492.15 Mn |
| Mar 31, 2025 | 551.84 Mn |
| Dec 31, 2024 | 590.33 Mn |
| Sep 30, 2024 | 627.86 Mn |
| Jun 30, 2024 | 656.22 Mn |
| Mar 31, 2024 | 425.67 Mn |
| Dec 31, 2023 | 453.90 Mn |
| Sep 30, 2023 | 468.82 Mn |
| Jun 30, 2023 | 499.57 Mn |
| Mar 31, 2023 | 485.65 Mn |
| Dec 31, 2022 | 535.03 Mn |
| Sep 30, 2022 | 586.13 Mn |
| Jun 30, 2022 | 604.62 Mn |
| Mar 31, 2022 | 419.47 Mn |
| Dec 31, 2021 | 425.37 Mn |
| Sep 30, 2021 | 445.47 Mn |
API Access
Cullinan Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CGEM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CGEM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CGEM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();